During the last session, Gossamer Bio Inc. (NASDAQ:GOSS)’s traded shares were 1.56 million, with the beta value of the company hitting 1.05. At the end of the trading day, the stock’s price was $12.25, reflecting an intraday gain of 3.99% or $0.47. The 52-week high for the GOSS share is $14.30, that puts it down -16.73 from that peak though still a striking 53.96% gain since the share price plummeted to a 52-week low of $5.64. The company’s market capitalization is $1.00B, and the average intraday trading volume over the past 10 days was 1.04 million shares, and the average trade volume was 1.30 million shares over the past three months.
Gossamer Bio Inc. (GOSS) received a consensus recommendation of a Buy from analysts. That translates to a mean rating of 1.80. GOSS has a Sell rating from 0 analyst(s) out of 9 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 2 suggest Overweight, and 7 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -$0.7.
Gossamer Bio Inc. (NASDAQ:GOSS) trade information
Gossamer Bio Inc. (GOSS) registered a 3.99% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 3.99% in intraday trading to $12.25 this Wednesday, 08/03/22, hitting a weekly high. The stock’s 5-day price performance is 2.77%, and it has moved by 39.36% in 30 days. Based on these gigs, the overall price performance for the year is 56.05%. The short interest in Gossamer Bio Inc. (NASDAQ:GOSS) is 13.51 million shares and it means that shorts have 6.94 day(s) to cover.
The consensus price target of analysts on Wall Street is $15.78, which implies an increase of 22.37% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $12.00 and $21.00 respectively. As a result, GOSS is trading at a discount of -71.43% off the target high and 2.04% off the low.
Gossamer Bio Inc. (GOSS) estimates and forecasts
Statistics show that Gossamer Bio Inc. has outperformed its competitors in share price, compared to the industry in which it operates. Gossamer Bio Inc. (GOSS) shares have gone up 28.95% during the last six months, with a year-to-date growth rate more than the industry average at 15.65% against 1.00. Yet analysts are ramping up their growth forecast for the fiscal year 2022. Revenue is predicted to grow 12.50% this quarter and then jump 18.80% in the quarter after that.
While earnings are projected to return 12.00% in 2022, the next five years will return 5.20% per annum.
Gossamer Bio Inc. is due to release its next quarterly earnings between February 23 and February 28. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Gossamer Bio Inc. (NASDAQ:GOSS)’s Major holders
Gossamer Bio Inc. insiders own 10.57% of total outstanding shares while institutional holders control 89.75%, with the float percentage being 100.36%. HHLR Advisors, LTD is the largest shareholder of the company, while 208 institutions own stock in it. As of Mar 30, 2022, the company held over 7.42 million shares (or 9.62% of all shares), a total value of $64.41 million in shares.
The next largest institutional holding, with 5.65 million shares, is of Vanguard Group, Inc. (The)’s that is approximately 7.33% of outstanding shares. At the market price on Mar 30, 2022, these shares were valued at $49.08 million.
Also, the Mutual Funds coming in first place with the largest holdings of Gossamer Bio Inc. (GOSS) shares are SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF and Federated Hermes Kaufmann Small Cap Fund. Data provided on Jun 29, 2022 indicates that SPDR (R) Ser Tr-SPDR (R) S&P (R) Biotech ETF owns about 2.68 million shares. This amounts to just over 3.47 percent of the company’s overall shares, with a $22.41 million market value. The same data shows that the other fund manager holds slightly less at 2.5 million, or about 3.24% of the stock, which is worth about $17.27 million.